MedPath

Study the effects of pretreatment with myoinositol on oocyte quality in patients with polycyctic ovary syndrome

Phase 2
Conditions
polycystic ovary syndrome disorder.
Polycystic ovarian syndrome
Registration Number
IRCT2017021432525N2
Lead Sponsor
Shahrekord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
54
Inclusion Criteria

inclusion criteria:infertile women with PCOS over 35 years old candidate for IVF procedure;normal sperm test and hysterosalpingography;agreement of patients for participation in the study.
exclusion criteria:patients must not use any other medication during the study;any other disease,history of abdomen and pelvic surgery,male infertility,abnormal hysterosalpingography or abnormal prolactin level;patiens leave the study on their own decision

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath